Abstract:Background: The protein p53, encoded by the most frequently mutated gene TP53 in human cancers, has diverse functions in tumor suppression. As a best known transcription factor, p53 can regulate various fundamental cellular responses, ranging from the cell-cycle arrest, DNA repair, senescence to the programmed cell death (PCD), which includes autophagy, apoptosis, ferroptosis, cuproptosis, pyroptosis and disulfidoptosis. Accumulating evidence has indicated that the tumor microenvironment (TME), N6-methyladenosine (m6A) modification and diverse PCD are important for the progression, proliferation and metastases of cancers. Aim of review: This paper aims to systematically and comprehensively summarize the multiple roles of p53 in the development of cancers from the regulation of TME, m6A Modification and diverse PCD. Key scientific concepts of review: TME, a crucial local homeostasis environment, influences every step of tumorigenesis and metastasis. m6A, the most prevalent and abundant endogenous modification in eukaryotic RNAs, plays an essential role in various biological processes, containing the progression of cancers. Additionally, PCD is an evolutionarily conserved mechanism of cell suicide and a common process in living organisms. Some forms of PCD contribute to the occurrence and development of cancer. However, the complex roles of p53 within the TME, m6A modification and diverse PCD mechanisms are still not completely understood. Presently, the function roles of p53 including the wild-type and mutant p53 in different context are summarized. Additionally, the interaction between the cancer immunity, cancer cell death and RNA m6A methylation and the p53 regulation during the development and progress of cancers were discussed. Moreover, the key molecular mechanisms by which p53 participates in the regulation of TME, m6A and diverse PCD are also explored. All the findings will facilitate the development of novel therapeutic approaches.

p53/MDM2 signaling pathway in aging, senescence and tumorigenesis

Common Pathogenetic Mechanisms Underlying Aging and Tumor and Means of Interventions.

Senescence regulation by the p53 protein family.

Senescence Reprogramming by MTHFD2 Deficiency Facilitates Tumor Progression

Role of p53 in the Regulation of Cellular Senescence

Linked regulation of genome integrity and senescence-associated inflammation by p53

Targeting Mouse Double Minute 2: Current Concepts in DNA Damage Repair and Therapeutic Approaches in Cancer.

Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis

Small Molecule Agents Targeting the P53-Mdm2 Pathway for Cancer Therapy

p53 signaling and autophagy in cancer: a revolutionary strategy could be developed for cancer treatment.

Tumor Suppression by P53: Making Cells Senescent.

Functional Diversity of P53 in Human and Wild Animals

P53, Oxidative Stress, and Aging

Inhibition of DYRK1A-EGFR axis by p53-MDM2 cascade mediates the induction of cellular senescence

Tumor Promoting Aspects of Senescence in Cancer Progression

Cellular senescence in cancer: molecular mechanisms and therapeutic targets

Senescence Aging, And Malignant Transformation Mediated By P53 In Mice Lacking The Brcal Full-Length Isoform

A mitochondria-regulated p53-CCF circuit integrates genome integrity with inflammation

Multiple roles of p53 in cancer development: Regulation of tumor microenvironment, m6A modification and diverse cell death mechanisms

SIRT1 and p53, effect on cancer, senescence and beyond.

The P53/mirnas/ccna2 Pathway Serves As a Novel Regulator of Cellular Senescence: Complement of the Canonical P53/p21 Pathway